For IHC, the liver tissues were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned (4-μm thickness). They were then dewaxed, hydrated for 30 min at room temperature, and incubated overnight at 4 °C with the following primary antibodies: anti-CD31 (1:1000, Proteintech, Wuhan, China); anti-CD206 (1:10000, Proteintech, Wuhan, China), anti-HECTD3 (1:400, BIOS, Beijing, China). Subsequently, the slides were incubated with a horseradish peroxidase-labeled secondary antibody, and the immunoreactivity was visualized with 3,3-diaminobenzidine tetrahydrochloride (DAB). Tissue sections were counterstained with hematoxylin and visualized using Leica Microsystems at 200 × and 400 × magnification. Image-pro plus 6.0 was used for image analysis (Media CybernetiHOPE, Inc., Rockville, MD, USA).
IF was performed as previously reported44 (link). Specifically, the sections or cell slides were incubated with anti-CD31, anti-CD206, anti-TRAF3 (1:100, Proteintech, Wuhan, China), anti-Ly6G (1:100, Novus, Littleton, USA), anti-MPO (1:200, Servicebio, Wuhan, China), anti-CD11b (1:500, Servicebio, Wuhan, China) and anti-HECTD3 (1:100, BIOS, Beijing, China) antibodies. After washing, the slides were incubated with Alexa Fluor 594-conjugated secondary antibodies or Alexa Fluor 488-conjugated secondary antibodies (1:200, Proteintech, Wuhan, China).
Free full text: Click here